Esperienze in tempo reale, attività fisica ed esiti biologici nella recovery personale di persone con disturbo mentale grave assistite in strutture residenziali psichiatriche: un trial clinico multicentrico non randomizzato

Summary. Purpose. In Italy, people with severe mental disorders (SMDs) are often residents in mental health supported accommodations (SAs). SMDs are associated with persistent symptoms, functional impairment, and social exclusion. Although the goal of SAs is to promote personal recovery, defined as living life to the fullest potential, the adoption of such approaches remains challenging. The study aims to assess the effectiveness of personal recovery-oriented compared with standard treatment in enhancing patients' functioning, integrating the assessment with biological markers and innovative digital technologies. In addition, the study investigates whether such interventions can reduce the burden experienced by caregivers and mental health professionals. Methods. EMPOWER-RES is a nonrandomized multicenter clinical trial comparing patients in SAs receiving personal recovery-oriented treatment (n=36) and standard treatment (n=36). Patients will be matched by sex, age, and diagnosis. The personal recovery-oriented treatment will use the Mental Health Recovery Star, a tool that represents ten life dimensions and monitors the stages of change. Standardized assessments will be administered to patients, caregivers, and professionals baseline and after six months. A mobile application will collect real-time data on patients' daily experiences, mood and social interactions, while accelerometers will monitor their physical activity and sleep-wake rhythms. Results. Not yet available. Discussion and conclusions. The hypothesis is that personal recovery will significantly increase Personal and Social Functioning (PSP score ≥5 points at 6 months), reduce caregiver burden and professional burnout. The study will provide new insights to optimize mental health services and personalized therapeutic options for patients with SMDs living in SAs.